Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm

Stephanie N. Zimmer, Madeleine E. Lemieux, Bijal P. Karia, Claudia Day, Ting Zhou, Qing Zhou, Andrew L. Kung, Uthra Suresh, Yidong Chen, Marsha C Kinney, Alexander J Bishop, Vivienne I. Rebel

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Myelodysplastic syndrome is a complex family of preleukemic diseases in which hematopoietic stem cell defects lead to abnormal differentiation in one or more blood lineages. Disease progression is associated with increasing genomic instability and a large proportion of patients go on to develop acute myeloid leukemia. Primarily a disease of the elderly, it can also develop after chemotherapy. We have previously reported that CREB binding protein (Crebbp) heterozygous mice have an increased incidence of hematological malignancies, and others have shown that CREBBP is one of the genes altered by chromosomal translocations found in patients suffering from therapy-related myelodysplastic syndrome. This led us to investigate whether hematopoietic tumor development in Crebbp+/- mice is preceded by a myelodysplastic phase and whether we could uncover molecular mechanisms that might contribute to its development. We report here that Crebbp+/- mice invariably develop myelodysplastic/myeloproliferative neoplasm within 9 to 12 months of age. They are also hypersensitive to ionizing radiation and show a marked decrease in poly(ADP-ribose) polymerase-1 activity after irradiation. In addition, protein levels of XRCC1 and APEX1, key components of base excision repair machinery, are reduced in unirradiated Crebbp+/- cells or upon targeted knockdown of CREBBP levels. Our results provide validation of a novel myelodysplastic/myeloproliferative neoplasm mouse model and, more importantly, point to defective repair of DNA damage as a contributing factor to the pathogenesis of this currently incurable disease.

Original languageEnglish (US)
JournalExperimental Hematology
Volume40
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Myelodysplastic Syndromes
Radiation
CREB-Binding Protein
Neoplasms
Genetic Translocation
Genomic Instability
Hematologic Neoplasms
Hematopoietic Stem Cells
Ionizing Radiation
Acute Myeloid Leukemia
DNA Repair
DNA Damage
Disease Progression
Drug Therapy
Incidence
Genes
Mouse Crebbp protein
Proteins
Therapeutics
Poly (ADP-Ribose) Polymerase-1

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Hematology

Cite this

Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm. / Zimmer, Stephanie N.; Lemieux, Madeleine E.; Karia, Bijal P.; Day, Claudia; Zhou, Ting; Zhou, Qing; Kung, Andrew L.; Suresh, Uthra; Chen, Yidong; Kinney, Marsha C; Bishop, Alexander J; Rebel, Vivienne I.

In: Experimental Hematology, Vol. 40, No. 4, 04.2012.

Research output: Contribution to journalArticle

Zimmer, Stephanie N. ; Lemieux, Madeleine E. ; Karia, Bijal P. ; Day, Claudia ; Zhou, Ting ; Zhou, Qing ; Kung, Andrew L. ; Suresh, Uthra ; Chen, Yidong ; Kinney, Marsha C ; Bishop, Alexander J ; Rebel, Vivienne I. / Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm. In: Experimental Hematology. 2012 ; Vol. 40, No. 4.
@article{83431997ffef4478afc9dd1dabebc0ac,
title = "Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm",
abstract = "Myelodysplastic syndrome is a complex family of preleukemic diseases in which hematopoietic stem cell defects lead to abnormal differentiation in one or more blood lineages. Disease progression is associated with increasing genomic instability and a large proportion of patients go on to develop acute myeloid leukemia. Primarily a disease of the elderly, it can also develop after chemotherapy. We have previously reported that CREB binding protein (Crebbp) heterozygous mice have an increased incidence of hematological malignancies, and others have shown that CREBBP is one of the genes altered by chromosomal translocations found in patients suffering from therapy-related myelodysplastic syndrome. This led us to investigate whether hematopoietic tumor development in Crebbp+/- mice is preceded by a myelodysplastic phase and whether we could uncover molecular mechanisms that might contribute to its development. We report here that Crebbp+/- mice invariably develop myelodysplastic/myeloproliferative neoplasm within 9 to 12 months of age. They are also hypersensitive to ionizing radiation and show a marked decrease in poly(ADP-ribose) polymerase-1 activity after irradiation. In addition, protein levels of XRCC1 and APEX1, key components of base excision repair machinery, are reduced in unirradiated Crebbp+/- cells or upon targeted knockdown of CREBBP levels. Our results provide validation of a novel myelodysplastic/myeloproliferative neoplasm mouse model and, more importantly, point to defective repair of DNA damage as a contributing factor to the pathogenesis of this currently incurable disease.",
author = "Zimmer, {Stephanie N.} and Lemieux, {Madeleine E.} and Karia, {Bijal P.} and Claudia Day and Ting Zhou and Qing Zhou and Kung, {Andrew L.} and Uthra Suresh and Yidong Chen and Kinney, {Marsha C} and Bishop, {Alexander J} and Rebel, {Vivienne I.}",
year = "2012",
month = "4",
doi = "10.1016/j.exphem.2011.12.004",
language = "English (US)",
volume = "40",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm

AU - Zimmer, Stephanie N.

AU - Lemieux, Madeleine E.

AU - Karia, Bijal P.

AU - Day, Claudia

AU - Zhou, Ting

AU - Zhou, Qing

AU - Kung, Andrew L.

AU - Suresh, Uthra

AU - Chen, Yidong

AU - Kinney, Marsha C

AU - Bishop, Alexander J

AU - Rebel, Vivienne I.

PY - 2012/4

Y1 - 2012/4

N2 - Myelodysplastic syndrome is a complex family of preleukemic diseases in which hematopoietic stem cell defects lead to abnormal differentiation in one or more blood lineages. Disease progression is associated with increasing genomic instability and a large proportion of patients go on to develop acute myeloid leukemia. Primarily a disease of the elderly, it can also develop after chemotherapy. We have previously reported that CREB binding protein (Crebbp) heterozygous mice have an increased incidence of hematological malignancies, and others have shown that CREBBP is one of the genes altered by chromosomal translocations found in patients suffering from therapy-related myelodysplastic syndrome. This led us to investigate whether hematopoietic tumor development in Crebbp+/- mice is preceded by a myelodysplastic phase and whether we could uncover molecular mechanisms that might contribute to its development. We report here that Crebbp+/- mice invariably develop myelodysplastic/myeloproliferative neoplasm within 9 to 12 months of age. They are also hypersensitive to ionizing radiation and show a marked decrease in poly(ADP-ribose) polymerase-1 activity after irradiation. In addition, protein levels of XRCC1 and APEX1, key components of base excision repair machinery, are reduced in unirradiated Crebbp+/- cells or upon targeted knockdown of CREBBP levels. Our results provide validation of a novel myelodysplastic/myeloproliferative neoplasm mouse model and, more importantly, point to defective repair of DNA damage as a contributing factor to the pathogenesis of this currently incurable disease.

AB - Myelodysplastic syndrome is a complex family of preleukemic diseases in which hematopoietic stem cell defects lead to abnormal differentiation in one or more blood lineages. Disease progression is associated with increasing genomic instability and a large proportion of patients go on to develop acute myeloid leukemia. Primarily a disease of the elderly, it can also develop after chemotherapy. We have previously reported that CREB binding protein (Crebbp) heterozygous mice have an increased incidence of hematological malignancies, and others have shown that CREBBP is one of the genes altered by chromosomal translocations found in patients suffering from therapy-related myelodysplastic syndrome. This led us to investigate whether hematopoietic tumor development in Crebbp+/- mice is preceded by a myelodysplastic phase and whether we could uncover molecular mechanisms that might contribute to its development. We report here that Crebbp+/- mice invariably develop myelodysplastic/myeloproliferative neoplasm within 9 to 12 months of age. They are also hypersensitive to ionizing radiation and show a marked decrease in poly(ADP-ribose) polymerase-1 activity after irradiation. In addition, protein levels of XRCC1 and APEX1, key components of base excision repair machinery, are reduced in unirradiated Crebbp+/- cells or upon targeted knockdown of CREBBP levels. Our results provide validation of a novel myelodysplastic/myeloproliferative neoplasm mouse model and, more importantly, point to defective repair of DNA damage as a contributing factor to the pathogenesis of this currently incurable disease.

UR - http://www.scopus.com/inward/record.url?scp=84862805858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862805858&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2011.12.004

DO - 10.1016/j.exphem.2011.12.004

M3 - Article

C2 - 22198154

AN - SCOPUS:84862805858

VL - 40

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 4

ER -